Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. Dezember 2024 09:00 ET | Quelle: invIOs GmbH

invIOs to present progress across oncology pipeline during JP Morgan Week 2025

VIENNA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP Morgan week activities in...
21. Dezember 2023 04:00 ET | Quelle: invIOs GmbH

invIOs to attend JP Morgan Week in San Francisco in January

VIENNA, Austria, Dec. 21, 2023 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP Morgan week...
14. Dezember 2022 08:00 ET | Quelle: invIOs GmbH

invIOs to present at Biotech Showcase

VIENNA, Austria, Dec. 14, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces that CEO Peter...
07. Dezember 2017 07:55 ET | Quelle: Big3Bio

Big3Bio Introduces Inaugural Sponsors and Partners of BioWeekSF

SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Big3Bio is proud to announce the leading industry organizations that have signed on as inaugural partners and sponsors of BioWeekSF, the site...